Theranovir is a scientifically promising biotech startup with verifiable accolades (i-Lab 2020, HEC-Challenge+). The project addresses critical health issues (cancer, obesity) with novel patented technology. However, the submission contains significant inaccuracies, specifically the claim that 'most people have used my product,' which is factually impossible for a specialized pre-clinical/clinical stage biotech company. While the technical foundation is strong, the 'Proof of Usefulness' score is heavily penalized by the lack of commercial traction and the erroneous claims in the input data, placing it in the 'minimal traction' category relative to the evaluation baseline.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline